Advertisement

Protein A Immunoadsorption/Immunoactivation: A Critical Review

  • Mehmet F. Fer
  • Robert K. Oldham
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 15)

Abstract

Over the past several years, reports have been published describing antitumor effects of autologous plasma after contact with protein A or bacterial products containing protein A (Bansal et al., 1978; Bensinger et al., 1981; Holohan et al., 1982; Jones et al., 1980; Terman et al., 1980, 1981). Although the efficacy of these manipulations, the best reagents to use, and the mechanism of action are all unclear, considerable enthusiasm regarding the effects of protein A has been generated. This chapter will review the available information on protein A-related plasma immunoadsorption/immunoactivation studies for cancer therapy and to summarize current thoughts and controversies.

Keywords

Thrombotic Thrombocytopenic Purpura Antitumor Response Circulate Immune Complex Autologous Plasma Plasma Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baldwin, R. W., Price, M. R., and Robins, R. A., 1972, Blocking of lymphocyte-mediated cytotoxicity for rate hepatoma cells by tumor-specific antigen-antibody complexes, Nature 238: 185–187.CrossRefGoogle Scholar
  2. Baldwin, R. W., Price, M. R., and Robins, R. A., 1973, Significance of serum factors modifying cellular immune responses to growing tumors, Br. J. Cancer (Suppl.) 28: 37–47.Google Scholar
  3. Balint, J., Ikeda, Y., Langone, J. J., Shearer, W. T., Daskal, I., Meek, K., Cook, G., Henry, J., and Terman, D. S., 1984, Tumoricidal response following perfusion of plasma over immobilized protein A: Identification of immunoglobulin oligomers in serum after perfusion and their partial characterization, Cancer Res. 44: 734–743.PubMedGoogle Scholar
  4. Bansal, S. C., Bansal, B. R., Thomas, H. L., Siegel, P. D., Rhoads, J. E., Cooper, D. R., Terman, D. S., and Mark, R., 1978, Ex-vivo removal of serum IgG in a patient with colon carcinoma: Biochemical, immunological and histological observations, Cancer 42: 1–18.PubMedCrossRefGoogle Scholar
  5. Bensinger, W. I., Kinet, J. P., Hennen, G., Franckenne, F., Schaus, C., Saint-Remy, M., Hoyoux, P., and Mahieu, P., 1981, Plasma perfused over immobilized protein A for breast cancer, N. Engl. J. Med. 306: 935–937.Google Scholar
  6. Bensinger, W. I., Buckner, C. D., Clift, R. A., and Thomas, E. D., 1984, Clinical trials with staphylococcal protein A, J. Biol. Resp. Modif. 3: 347–351.Google Scholar
  7. Bertram, J., Hengst, J. C. D., and Mitchell, M. S., 1984, Staph protein A immunoadsorptive column induces mitogenicity in perfused plasma, J. Biol. Resp. Modif. 3: 235–240.Google Scholar
  8. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B., 1975, Induced serum factor that causes necrosis of tumors, Proc. Natl Acad. Sci. USA 72: 3666–3670.PubMedCrossRefGoogle Scholar
  9. Cohen, D., Fer, M. F., Pearson, J. W., and Herberman, R. B., 1984, Treatment of canine transmissible venereal tumor by intraveneous administration of protein A, J. Biol. Resp. Modif. 3: 271–277.Google Scholar
  10. Cooley, W. B., 1906, Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and bacillus prodigiosus, Am. J. Med. Sci. 131: 375–430.Google Scholar
  11. Day, N. K., Engelman, R. W., Liu, W. T., Trang, T., and Good, R. A., 1984, Remission of lymphoma leukemia in cats following ex-vivo immunosorption therapy using Staphylococcus protein A, J. Biol. Resp. Modif. 3: 278–285.Google Scholar
  12. Fer, M. F., Beman, J. A.. Stevenson. H. C., Maluish, A., Moratz, C., Delawter, T., Foon, K., Herberman, R. B., Oldham, R. K., Terman, D. S., Young, J. B., and Daskal, Y., 1984, A trial of autologous plasma perfused over Protein A in patients with breast cancer, J. Biol. Resp. Modif. 3: 352–358.Google Scholar
  13. Forsgren, A., and Sjoquist, J., 1966, “Protein A” from S. aureus. I. Pseudoimmune reaction with human gamma-globulin, J. Immunol 97:822–827.PubMedGoogle Scholar
  14. Gordon, B. R., Matus, R. E., Saal, S. D., MacEwen, E. G., Hurwitz, A. I., Stenzel, K. H., and Rubin, A. L., 1983, Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus, J. Natl. Cancer Inst. 70: 1127–1133.PubMedGoogle Scholar
  15. Gordon, B. R., Matus, R. E., Hurvitz, A. I., MacEwen, E. G., Saal, S. D., Stenzel, K. H., Rubin, A. L., and Hyden, H., 1984, Perfusion of plasma over S. aureus: Release of bacterial products is related to regression of tumor, J. Biol. Resp. Modif. 3: 266–270.Google Scholar
  16. Hanna, M. G., Jr., Key, M. E., and Oldham, R. K., 1983, Biology of cancer therapy: Some new insights into adjuvant treatment of metastatic solid tumors, J. Biol. Resp. Modif. 2: 295–309.Google Scholar
  17. Hellstrom, I., and Hellstrom, K. E., 1970, Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to Moloney sarcomas, Int. J. Cancer 5: 195–201.PubMedCrossRefGoogle Scholar
  18. Hellstrom, I., and Hellstrom, K. E., 1976, Microcytotoxicity assay of cell mediated tumor immunity and blocking serum factors, in: In Vitro Methods of Cell Mediated and Tumor Immunity ( R. B. Bloom and J. R. David, eds.), pp. 553–591, Academic Press, New York.Google Scholar
  19. Holohan, T., Phillips, T. M., Bowles, C., and Deisseroth, A., 1982, Regression of canine mammary carcinoma after immunoadsorption therapy, Cancer Res. 42: 3663–3668.PubMedGoogle Scholar
  20. Jones, F., Yoshida, L., Ladiges, W., and Kenny, M., 1980, Treatment of feline leukemia and reversal of FeLV by ex vivo removal of IgG: A preliminary report, Cancer 46: 675–684.PubMedCrossRefGoogle Scholar
  21. Jones, F. R., Grant, C. K., and Snyder, H. W., 1984, Lymphosarcoma and persistent feline leukemia virus infection of pet cats: A system to study responses during extracorporeal treatments, J. Biol. Resp. Modif. 3: 286–292.Google Scholar
  22. Kiprow, D. D., Lippert, R., Jones, F. R., Lagios, M. D., Balint, J. P. and Cohen, R. J., 1984, Extracorporeal perfusion of plasma over immobilized protein A in a patient with Kaposi’s sarcoma and acquired immunodeficiency, J. Biol. Resp. Modif. 3: 341–346.Google Scholar
  23. Korec, S., Smith, F. P., Schein, P. S., and Phillips, T. M., 1984, Clinical experiences with extra-corporeal immunoperfusion of plasma from cancer patients, J. Biol. Resp. Modif. 3: 330–335.Google Scholar
  24. Kronvall, G., and Frommel, D., 1970, Definition of staphylococcal protein A reactivity for human immunoglobulin G fragments, Immunochemistry 7: 124–127.PubMedCrossRefGoogle Scholar
  25. Kull, F. C., Jr., and Cuatrecasas, P., 1981, Possible requirement of internalization in the mechanism of in vitro cytoxicity in tumor necrosis serum, Cancer Res. 41: 4885–4890.PubMedGoogle Scholar
  26. Langone, J. J., 1984, Complexes containing Staphylococcus aureus protein A: Composition and biological activity, J. Biol. Resp. Modif. 3: 241–246.Google Scholar
  27. Langone, J. J., Boyle, M. D. P., and Borsos, T., 1978a, Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG, J. Immunol. 121: 327–332.PubMedGoogle Scholar
  28. Langone, J. J., Boyle, M. D. P., and Borsos, T., 1978b, Studies on the interaction between protein A and immunoglobulin G. II. Composition and activity of complexes formed between Protein A and IgG, J. Immunol. 121: 333–338.PubMedGoogle Scholar
  29. MacKintosh, F. R., Bennett, K., Schiff, S., Shields, J., and Hall, S. W., 1983, Treatment of advanced malignancy with plasma perfused over staphylococcal protein A, West. J. Med. 139: 36–42.PubMedGoogle Scholar
  30. MacKintosh, F. R., Bennett, K., and Hall, S. W., 1984, Clinical response to protein-A tested plasma infusions and in vitro correlation, J. Biol. Resp. Modif. 3: 336–340.Google Scholar
  31. Messerschmidt, G., Bowles, C., Dean, D., Parker, M., Lester, R., Dowling, R., Holohan, T., Osborne, L., Schaff, B. F., McCormack, K., Corbitt, R., Phillips, T., Glatstein, E., and Deisseroth, A., 1982a, Phase I trial of Staphylococcus aureus Cowan I immunoperfusion, Cancer Treat. Rep. 66: 2027–2031.PubMedGoogle Scholar
  32. Messerschmidt, G. L., Steis, R., Dowling, R., Parrillo, J., Parker, M., Shelhammer, J., Brown, R., Herberman, R., Maluish, A., Phillips, T., Voith, M., Diehl, L., Bowles, C., Young, R. C., Glatstein, E., and Deisseroth, A., 1982b, Phase I trials of ex-vivo plasma perfusion with Staphylococcus aureus Cowan strain I and protein A charcoal in malignancies, Proc. Soc. Gin. Oncol 1: 80.Google Scholar
  33. Messerschmidt, G. L., Bowles, C. A., Henry, D., and Deisseroth, A. B., 1984, Clinical trials with Staphylococcus aureus and protein A in the treatment of malignant disease, J. Biol Resp. Modif. 3: 325–329.Google Scholar
  34. Miller, W. J., Branda, R. F., Hurf, D. D., Wachsman, W., Nelson, N. L., and Jacob, H. S., 1982, Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis, Blood 59: 1344–1347.PubMedGoogle Scholar
  35. Oldham, R. K., 1984, Introduction, J. Biol Resp. Modif. 3: 229–230.Google Scholar
  36. Ray, P. K., Idiculla, A., Mark, R., Rhoads, J. E., Thomas, H., Bassett, J. G., and Cooper, D. R., 1982, Extracorporeal immunoadsorption of plasma from a metastatic colon carcinoma patient by protein A containing non-viable Staphylococcus aureus, Cancer 49: 1800–1809.PubMedCrossRefGoogle Scholar
  37. Sjogren, H. O., Hellstrom, I., Bansal, S. C., and Hellstrom, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes, Proc. Natl Acad. Sci. USA 68: 1372–1375.PubMedCrossRefGoogle Scholar
  38. Steele, G., Jr., Ankerst, J., and Sjogren, H. O., 1974, Alteration of in vivo antitumor activity of tumor-bearer sera by absorption with Staphylococcus aureus Cowan I, Int. J. Cancer 14: 83–92.PubMedCrossRefGoogle Scholar
  39. Sukumar, S., Zbar, B., Terata, N., and Langone, J., 1984, Plasma therapy of primary rat mammary carcinoma, J. Biol Resp. Modif. 3: 303–315.Google Scholar
  40. Terman, D. S., Yamamoto, T., Mattioli, M., Cook, G., Tillquist, R., Henry J., Poser R., and Daskal, Y., 1980, Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowan I: Description of acute tumoricidal response-Morphologic, histologic, immunohistochemical, immunologic, and serologic findings, J. Immunol 124: 795–805.PubMedGoogle Scholar
  41. Terman, D. S., Young, J. B.; Shearer, W. T., Ayus, C.; Lehane, D.S. Mattioli, C., Espada, R., Howell, J. F., Yamamoto, T., Zaleski, H. I., Miller, L., Frommer, P., Feldman, L., Henry, J. F., Tillquist, R., Cook, G., and Daskal, Y., 1981, Preliminary observations of tumoricidal response following plasma perfusion over immobilized protein A in adenocarcinoma of the breast, N. Engl J. Med. 305: 1195–1200.PubMedCrossRefGoogle Scholar
  42. Zimmerman, S. E., Smith, F. P., Phillips, T. M., Coffey, R. J., and Schein, P. S., 1982, Gastric carcinoma and thrombotic thrombocytopenic purpura: Association with plasma immune complex concentrations, Br. Med. J. 284: 1432–1434.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Mehmet F. Fer
    • 1
  • Robert K. Oldham
    • 2
  1. 1.Section of Hematology/OncologyUniversity of Kentucky Medical CenterLexingtonUSA
  2. 2.Biological Therapy InstituteFranklinUSA

Personalised recommendations